Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.

This study indicated the association between the FRGs and prognosis of patients with LUSC. Targeting ferroptosis may serve as a novel potential therapeutic alternative for LUSC.